Blood Flow Restriction Therapy (BFRT) is defined as “the brief and intermittent occlusion of arterial and venous blood flow using a tourniquet while at rest or exercising”.

Prostate cancer is one of the most common cancers in American men. It is estimated that about 1 in 8 men are diagnosed during their lifetime and 1 in 41 will die from the disease. While a serious disease, most men with prostate cancer can continue to thrive with appropriate surgical treatment and monitoring for recurrence. As of January 2022, it is estimated there are 3.5 million living prostate cancer survivors in the US.